Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of anti...

ver descrição completa

Detalhes bibliográficos
Principais autores: Ratcliffe, H, Tiley, K, Longet, S, Tonry, C, Roarty, C, Watson, C, Amirthalingam, G, Vichos, I, Morey, E, Douglas, NL, Marinou, S, Plested, E, Aley, PK, Galiza, E, Faust, SN, Hughes, S, Murray, C, Roderick, MR, Shackley, F, Oddie, S, Lee, TWR, Turner, DPJ, Raman, M, Owens, S, Turner, PJ, Cockerill, H, Lopez Bernal, J, Ijaz, S, Poh, J, Shute, J, Linley, E, Borrow, R, Hoschler, K, Brown, KE, Carroll, MW, Klenerman, P, Dunachie, SJ, Ramsay, M, Voysey, M, Waterfield, T, Snape, MD
Formato: Journal article
Idioma:English
Publicado em: Elsevier 2023
_version_ 1826313134807187456
author Ratcliffe, H
Tiley, K
Longet, S
Tonry, C
Roarty, C
Watson, C
Amirthalingam, G
Vichos, I
Morey, E
Douglas, NL
Marinou, S
Plested, E
Aley, PK
Galiza, E
Faust, SN
Hughes, S
Murray, C
Roderick, MR
Shackley, F
Oddie, S
Lee, TWR
Turner, DPJ
Raman, M
Owens, S
Turner, PJ
Cockerill, H
Lopez Bernal, J
Ijaz, S
Poh, J
Shute, J
Linley, E
Borrow, R
Hoschler, K
Brown, KE
Carroll, MW
Klenerman, P
Dunachie, SJ
Ramsay, M
Voysey, M
Waterfield, T
Snape, MD
author_facet Ratcliffe, H
Tiley, K
Longet, S
Tonry, C
Roarty, C
Watson, C
Amirthalingam, G
Vichos, I
Morey, E
Douglas, NL
Marinou, S
Plested, E
Aley, PK
Galiza, E
Faust, SN
Hughes, S
Murray, C
Roderick, MR
Shackley, F
Oddie, S
Lee, TWR
Turner, DPJ
Raman, M
Owens, S
Turner, PJ
Cockerill, H
Lopez Bernal, J
Ijaz, S
Poh, J
Shute, J
Linley, E
Borrow, R
Hoschler, K
Brown, KE
Carroll, MW
Klenerman, P
Dunachie, SJ
Ramsay, M
Voysey, M
Waterfield, T
Snape, MD
author_sort Ratcliffe, H
collection OXFORD
description SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of antibody decline for nucleocapsid and spike protein in serum and oral fluid against SARS-CoV-2 within the pediatric population. No differences in seasonal coronaviruses antibody concentrations were found at baseline between cases and controls, suggesting no protective effect from pre-existing immunity against seasonal coronaviruses. Antibodies against seasonal betacoronaviruses were boosted in response to SARS-CoV-2 infection. In serum, anti-nucleocapsid antibodies fell below the threshold of positivity more quickly than anti-spike protein antibodies. These findings add to our understanding of protection against infection with SARS-CoV-2 within the pediatric population, which is important when considering pediatric SARS-CoV-2 immunization policies.
first_indexed 2024-09-25T04:08:17Z
format Journal article
id oxford-uuid:04b3d0c0-d730-487c-a37f-bfd7bced0a4a
institution University of Oxford
language English
last_indexed 2024-09-25T04:08:17Z
publishDate 2023
publisher Elsevier
record_format dspace
spelling oxford-uuid:04b3d0c0-d730-487c-a37f-bfd7bced0a4a2024-06-11T11:31:51ZSerum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:04b3d0c0-d730-487c-a37f-bfd7bced0a4aEnglishSymplectic ElementsElsevier2023Ratcliffe, HTiley, KLonget, STonry, CRoarty, CWatson, CAmirthalingam, GVichos, IMorey, EDouglas, NLMarinou, SPlested, EAley, PKGaliza, EFaust, SNHughes, SMurray, CRoderick, MRShackley, FOddie, SLee, TWRTurner, DPJRaman, MOwens, STurner, PJCockerill, HLopez Bernal, JIjaz, SPoh, JShute, JLinley, EBorrow, RHoschler, KBrown, KECarroll, MWKlenerman, PDunachie, SJRamsay, MVoysey, MWaterfield, TSnape, MDSARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive seasonal coronavirus antibodies and compare the rate of antibody decline for nucleocapsid and spike protein in serum and oral fluid against SARS-CoV-2 within the pediatric population. No differences in seasonal coronaviruses antibody concentrations were found at baseline between cases and controls, suggesting no protective effect from pre-existing immunity against seasonal coronaviruses. Antibodies against seasonal betacoronaviruses were boosted in response to SARS-CoV-2 infection. In serum, anti-nucleocapsid antibodies fell below the threshold of positivity more quickly than anti-spike protein antibodies. These findings add to our understanding of protection against infection with SARS-CoV-2 within the pediatric population, which is important when considering pediatric SARS-CoV-2 immunization policies.
spellingShingle Ratcliffe, H
Tiley, K
Longet, S
Tonry, C
Roarty, C
Watson, C
Amirthalingam, G
Vichos, I
Morey, E
Douglas, NL
Marinou, S
Plested, E
Aley, PK
Galiza, E
Faust, SN
Hughes, S
Murray, C
Roderick, MR
Shackley, F
Oddie, S
Lee, TWR
Turner, DPJ
Raman, M
Owens, S
Turner, PJ
Cockerill, H
Lopez Bernal, J
Ijaz, S
Poh, J
Shute, J
Linley, E
Borrow, R
Hoschler, K
Brown, KE
Carroll, MW
Klenerman, P
Dunachie, SJ
Ramsay, M
Voysey, M
Waterfield, T
Snape, MD
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title_full Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title_fullStr Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title_full_unstemmed Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title_short Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
title_sort serum hcov spike specific antibodies do not protect against subsequent sars cov 2 infection in children and adolescents
work_keys_str_mv AT ratcliffeh serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT tileyk serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT longets serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT tonryc serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT roartyc serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT watsonc serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT amirthalingamg serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT vichosi serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT moreye serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT douglasnl serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT marinous serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT plestede serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT aleypk serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT galizae serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT faustsn serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT hughess serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT murrayc serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT roderickmr serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT shackleyf serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT oddies serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT leetwr serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT turnerdpj serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT ramanm serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT owenss serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT turnerpj serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT cockerillh serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT lopezbernalj serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT ijazs serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT pohj serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT shutej serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT linleye serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT borrowr serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT hoschlerk serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT brownke serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT carrollmw serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT klenermanp serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT dunachiesj serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT ramsaym serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT voyseym serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT waterfieldt serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents
AT snapemd serumhcovspikespecificantibodiesdonotprotectagainstsubsequentsarscov2infectioninchildrenandadolescents